Targeting epidermal growth factor receptor to optimize chemoradiotherapy in locally advanced head and neck cancer: has biology been taken into account? [electronic resource]
Producer: 20110527Description: e283-4; author reply e285-7 p. digitalISSN:- 1527-7755
- Animals
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Carcinoma, Squamous Cell -- drug therapy
- Chemotherapy, Adjuvant
- ErbB Receptors -- antagonists & inhibitors
- Gefitinib
- Head and Neck Neoplasms -- drug therapy
- Humans
- Molecular Targeted Therapy
- Patient Selection
- Protein Kinase Inhibitors -- administration & dosage
- Quinazolines -- administration & dosage
- Radiation Tolerance
- Radiotherapy, Adjuvant
- Treatment Outcome
No physical items for this record
Publication Type: Letter; Comment
There are no comments on this title.
Log in to your account to post a comment.